Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-06-22

FDA Approved: QUETIAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's supplemental application for quetiapine (generic), updating the drug's labeling under the approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

SUPPL AP for QUETIAPINE (QUETIAPINE)